Clinical Research Forum named the BIOS CTCC study Early Outpatient COVID-19 Plasma Treatment Research Study (CSSC-004) one of the Top 10 2023 Clinical Research Achievement…
The Early Outpatient COVID-19 Plasma Treatment Research Study (CSSC-004) has been named a finalist for the 2023 Clinical Research Achievement Awards. The Clinical Research Achievement…
The Johns Hopkins University Division of Brain Injury Outcomes (BIOS) is pleased to announce the 2022 recipient of the Ann Dana Kusch Predoctoral Fellowship in…
The Early Outpatient COVID-19 Plasma Treatment Research Study (CSSC-004) had its final results published in The New England Journal of Medicine on March 30th, 2022.…
David Newman-Toker, MD, PhD, director of JHU’s Division of Neuro-Visual and Vestibular Disorders and a BIOS faculty member, was awarded the David Robinson Professorship in…
“I’m going to tell the story of the development of the Division of Brain Injury Outcomes into an academic research organization,” began BIOS director Daniel…
Attendees of the European Stroke Organisation Conference this month had a chance to learn about the OPTIMISTmain trial from its principal investigator, Victor Urrutia, MD.…
Earlier this year, the machine learning-based medical imaging solution that Johns Hopkins University’s BIOS team helped develop was chosen as an honoree in the Fast…
The Johns Hopkins University Division of Brain Injury Outcomes (BIOS) is pleased to announce the inaugural recipients of the Ann Dana Kusch Predoctoral Fellowship in…
Daniel Hanley, MD, BIOS division director, and Issam Awad, MD, director of neurovascular surgery at UChicago Medicine, joined the November 2019 episode of the Neurocritical…